Autosomal dominant axonal Charcot-Marie-Tooth disease type 2O (often shortened to CMT2O) is a very rare, inherited nerve disease. It mainly damages the long “wires” of the nerves (axons) in the legs and sometimes the arms. Because of this damage, signals between the brain, spinal cord, and muscles become weak. Over many years this can cause slowly increasing weakness, thin muscles, and some loss of feeling in the feet and hands. MalaCards+2uniprot.org+2
Autosomal dominant axonal Charcot-Marie-Tooth disease type 2O (CMT2O) is a very rare inherited nerve disease that mainly damages the long “wires” (axons) of the peripheral nerves in the legs and later the arms. It is usually caused by a single faulty copy of the DYNC1H1 gene, which codes for part of a motor protein (dynein) that moves important cargo inside nerve cells. MalaCards+1
Children with CMT2O often show delayed walking, frequent falls, foot deformities (such as high-arched feet called pes cavus), and slowly worsening weakness and muscle thinning in the feet and lower legs. Over time, some people also develop weakness in the hands, balance problems, scoliosis, and mild thinking or movement problems, but most keep the ability to walk in adult life. GARD Information Center+2ecommons.aku.edu+2
In CMT2O, the main problem is a harmful change (mutation) in a gene called DYNC1H1. This gene gives instructions to make a large motor protein called cytoplasmic dynein 1 heavy chain, which helps move materials along the nerve cell’s inner transport “rails.” When this protein does not work well, the long nerves in the legs are hurt first, so symptoms often start in childhood with clumsy walking or frequent falls. deciphergenomics.org+2Frontiers+2
This condition is called autosomal dominant because one changed copy of the gene from either mother or father is enough to cause the disease. It is called axonal because the axon part of the nerve is mainly affected, not the myelin coating. Over time the disease usually progresses slowly, and many people stay able to walk as adults, but they may need braces or special shoes. MalaCards+2cmtausa.org+2
Other names
Doctors and researchers use several names for the same disease. All of these point to the same basic condition:
Charcot-Marie-Tooth disease, axonal, type 2O – the formal medical name that shows it is an axonal form of CMT and belongs to the “type 2” group. MalaCards+1
Charcot-Marie-Tooth disease axonal type 2O – a very similar wording used in rare-disease databases. GARD Information Center+1
Autosomal dominant axonal Charcot-Marie-Tooth disease type 2O – this name stresses the pattern of inheritance (autosomal dominant) and that it is axonal. disease-ontology.org+1
Autosomal dominant Charcot-Marie-Tooth disease type 2O – a shorter form without the word “axonal,” but meaning the same disease. disease-ontology.org+1
Charcot-Marie-Tooth neuropathy axonal type 2O – focuses on “neuropathy,” which means a disease of peripheral nerves. informatics.jax.org+1
Charcot-Marie-Tooth neuropathy type 2O (CMT2O) – a shorter, practical name often used in clinical and research settings. MalaCards+1
Charcot-Marie-Tooth disease caused by mutation in DYNC1H1 – stresses that the disease is tied to a change in the DYNC1H1 gene. MalaCards+2monarchinitiative.org+2
DYNC1H1-related Charcot-Marie-Tooth disease – used sometimes inside the wider group of “DYNC1H1-related disorders.” NCBI+1
In CMT2O, a single harmful change in one copy of the DYNC1H1 gene is usually enough to cause the disease. Because the gene sits on one of the non-sex chromosomes (an autosome), both males and females can be affected in the same way. This pattern is called autosomal dominant inheritance. deciphergenomics.org+2disease-ontology.org+2
If a parent has CMT2O and carries the altered DYNC1H1 gene, each child has a 50% (1 in 2) chance to inherit that changed gene and develop the disease. Sometimes the mutation is de novo, which means it appears for the first time in the child and is not seen in either parent’s blood sample. In those cases the child may be the first person in the family with CMT2O. NCBI+2Frontiers+2
The DYNC1H1 protein is part of a “motor” that walks along microtubules inside the nerve cell and carries important cargo (like cell parts, signals, and waste) from the nerve endings back toward the cell body. When this motor does not work correctly, long motor and sensory nerves slowly become sick and start to shrink and die, especially in the lower legs. This leads to weakness, muscle wasting, and sensory loss in the feet and later the hands. ScienceDirect+2Frontiers+2
Types and clinical patterns
There is not an official set of “subtypes” inside CMT2O like there is for all CMT, but doctors notice different clinical patterns among people with the same DYNC1H1-related axonal neuropathy. These patterns can be thought of as “types” in daily practice: NCBI+2MalaCards+2
Classic childhood-onset CMT2O – symptoms start in early childhood with delayed walking, frequent falls, and difficulty running. Foot deformities and lower-leg muscle wasting slowly appear over time. MalaCards+1
Early-onset with strong lower-limb weakness – some children have very marked weakness in muscles that lift the foot, leading to severe foot drop and need for ankle-foot orthoses (braces) at a young age. MalaCards+2uniprot.org+2
Neuropathy with spasticity (stiff legs) – a few people show signs of both peripheral nerve damage and upper motor neuron involvement, such as tight, stiff legs and brisk reflexes, because some DYNC1H1 variants can affect the brain and spinal tracts as well. Frontiers+2OUP Academic+2
Neuropathy with skeletal problems – in some patients, scoliosis (curved spine), joint contractures, or clawed toes are prominent along with the nerve disease. These bone and joint changes reflect long-standing muscle imbalance. MalaCards+2uniprot.org+2
Neuropathy with mild learning or developmental difficulties – a small subgroup with DYNC1H1 mutations may have both CMT-like neuropathy and mild neurodevelopmental issues, because the gene is also important in brain development. NCBI+2Frontiers+2
Milder late-onset CMT2O-like picture – rare adults may be found to have a DYNC1H1 mutation after many years of only mild symptoms, such as high arches, easy fatigue in the legs, or subtle sensory loss. ecommons.aku.edu+2Springer Nature Link+2
These patterns are overlapping and not strict boxes, but they help doctors describe the range of how DYNC1H1-related axonal neuropathy can look in real life. NCBI+2Frontiers+2
Causes and contributing factors
For CMT2O, the true basic cause is always a disease-causing mutation in the DYNC1H1 gene. Other items below are factors that shape how severe or mild the disease becomes.
Pathogenic DYNC1H1 mutation – a harmful change in one copy of the DYNC1H1 gene is the main cause. This change alters the structure of the dynein motor protein so it cannot move cargo properly along the nerve cell’s microtubules. MalaCards+2deciphergenomics.org+2
Missense mutations in the motor domain – many patients have single-amino-acid changes in the “motor” region of dynein. This region generates movement, so mutations here can strongly impair axonal transport and lead to early and more severe neuropathy. Frontiers+2OUP Academic+2
Mutations in the tail or dimerization domain – other disease variants lie in the tail regions that help dynein pair up and bind cargo. Changes here can disturb how dynein complexes assemble and connect to vesicles, again disrupting axonal transport and causing nerve damage. Frontiers+2OUP Academic+2
Autosomal dominant inheritance from an affected parent – in many families, a parent with CMT2O passes the mutated gene copy to their child, leading to the same disease in the next generation. deciphergenomics.org+2disease-ontology.org+2
De novo mutation in the child – sometimes the DYNC1H1 mutation arises for the first time in the egg or sperm, or very early after fertilization, so the child is affected even though both parents test negative in blood. NCBI+2Frontiers+2
Parental germline mosaicism – rarely, a parent may carry the mutation only in some reproductive cells (germline) but not in their blood. This can explain more than one affected child in a family where parents appear unaffected on testing. NCBI+1
Allelic heterogeneity (different mutations in the same gene) – many different DYNC1H1 variants can cause similar CMT2O-like neuropathy, which is why two unrelated patients may have the same clinical picture but different exact DNA changes. Frontiers+2OUP Academic+2
Genetic modifiers in other neuropathy genes – variations in other genes involved in nerve structure or energy function may modify how serious DYNC1H1-related neuropathy becomes, leading to a wide range of severity. Springer Nature Link+2ScienceDirect+2
Disrupted retrograde axonal transport – dynein’s main job is to carry cargo from the nerve ending back to the cell body. When this system fails, waste builds up, growth signals fail, and the long axons in legs and arms gradually degenerate. This mechanism is central to axonal CMT, including CMT2O. ScienceDirect+2Frontiers+2
Impaired neuronal development – DYNC1H1 is also important in brain and spinal cord development. Some mutations disrupt how neurons migrate and connect during development, which can add spasticity or learning problems to the basic neuropathy picture. NCBI+2Frontiers+2
Chronic axonal degeneration and “dying-back” neuropathy – once axonal transport weakens, the far ends of the longest nerves (in the feet) lose support and begin to “die back,” causing progressive weakness and loss of sensation starting in the toes and feet. ScienceDirect+2uniprot.org+2
Secondary changes in myelin – although CMT2O is primarily axonal, long-standing axon injury can secondarily disturb the insulating myelin sheath, further slowing nerve signals and adding to disability. Springer Nature Link+2ecommons.aku.edu+2
Age-related nerve vulnerability – as people age, nerves naturally become more fragile. In someone with a DYNC1H1 mutation, this age-related change can unmask or worsen symptoms over time. Springer Nature Link+2ecommons.aku.edu+2
Repeated minor injuries to weak ankles and feet – weak ankle muscles and poor balance can lead to repeated sprains and micro-injuries, which do not cause the disease but can worsen pain and deformity. ecommons.aku.edu+2cmtausa.org+2
Co-existing health problems (like diabetes) – if a person with CMT2O also develops another cause of neuropathy, such as diabetes or vitamin B12 deficiency, the combined damage can make their nerve problems much worse. MedlinePlus+1
Exposure to strongly neurotoxic medicines – certain chemotherapy drugs, especially vincristine and sometimes paclitaxel, can produce severe additional nerve damage in people with inherited CMT and therefore should be used only with great caution. They do not cause CMT2O but can sharply worsen existing neuropathy. PMC+3PubMed+3Charcot-Marie-Tooth Disease+3
Poorly fitting shoes and lack of orthotic support – in people with foot deformities from CMT2O, shoes that do not support the arch and ankle can increase pain, calluses, and falls, adding to functional disability. cmtausa.org+2ecommons.aku.edu+2
Low physical activity because of fear of falling – many patients move less as they become afraid of tripping. While rest is sometimes needed, long-term low activity can weaken muscles further, making the neuropathy feel worse. cmtausa.org+2ecommons.aku.edu+2
Obesity or significant overweight – extra body weight can put more stress on weak ankles and knees and may raise the effort needed for walking, leading to more fatigue and mobility problems. cmtausa.org+2ecommons.aku.edu+2
Delay in diagnosis and support – late recognition of CMT2O can mean delayed use of braces, physiotherapy, and fall-prevention strategies, so preventable complications like contractures and injuries pile up over time. cmtausa.org+2ecommons.aku.edu+2
Symptoms and signs
Slowly progressive weakness in lower legs – most people first notice weakness in the muscles that lift the foot and toes. They may trip easily, have trouble running, or feel that their feet are “slapping” the ground. This weakness usually appears in childhood or adolescence and worsens slowly over many years. MalaCards+2uniprot.org+2
Muscle wasting in calves and feet – over time the lower-leg muscles shrink because they are not getting strong nerve signals. The legs can look “inverted champagne bottle” shaped, where the calves are thin and the thighs look relatively bigger. MalaCards+2uniprot.org+2
Foot drop and high-stepping gait – weak ankle muscles make it hard to lift the front of the foot, so the toes may drag. To avoid tripping, people often lift their knees higher when walking, which is called a steppage gait. ecommons.aku.edu+2MedlinePlus+2
High-arched feet (pes cavus) – many people with CMT2O have very high arches, clawed toes, or hammertoes. These deformities come from long-term muscle imbalance around the foot and ankle. MalaCards+2ecommons.aku.edu+2
Balance problems and frequent falls – because of muscle weakness and loss of position sense, standing on uneven ground, walking in the dark, or climbing stairs can be difficult and may cause falls. ecommons.aku.edu+2MedlinePlus+2
Numbness and reduced feeling in feet and lower legs – many patients notice decreased ability to feel light touch, vibration, or temperature in the toes and feet, which may very slowly extend up the legs. MalaCards+2uniprot.org+2
Mild to moderate neuropathic pain or discomfort – some people describe burning, tingling, or sharp pains in the feet or hands. Others feel mainly discomfort from cramps or tightness rather than strong pain. ecommons.aku.edu+1
Weakness in hands and fine-motor problems (later) – as the disease progresses, some patients develop difficulty with tasks like buttoning, writing, or opening jars because of weakness and slight muscle wasting in the hands. MalaCards+2uniprot.org+2
Reduced tendon reflexes – ankle reflexes and sometimes knee reflexes are often weak or absent on neurologic examination, which is typical for axonal CMT. ecommons.aku.edu+2uniprot.org+2
Delayed motor milestones in children – in childhood-onset CMT2O, walking may start later than usual, or running and jumping may always seem difficult compared with peers. MalaCards+2ecommons.aku.edu+2
Orthopedic complications (scoliosis, contractures) – long-standing muscle imbalance may lead to scoliosis (curved spine), tight heel cords, or contractures at the ankles and knees, which can further limit walking. MalaCards+2uniprot.org+2
Fatigue with walking or standing – because muscles must work harder to move weak limbs and compensate for deformity, people with CMT2O can tire easily, especially when walking long distances or standing still. ecommons.aku.edu+2cmtausa.org+2
Spasticity or increased tone in some patients – in a few cases where DYNC1H1 mutations also affect central pathways, the legs may feel stiff, and reflexes can be very brisk, giving a mixed picture of neuropathy plus upper motor neuron signs. Frontiers+2OUP Academic+2
Cognitive or learning difficulties (rare) – some individuals with DYNC1H1-related conditions have mild learning problems or developmental delays, reflecting the gene’s role in brain development, although this is less typical for pure CMT2O. NCBI+2Frontiers+2
Emotional impact and anxiety about progression – living with a chronic, slowly progressive disease can cause worry, sadness, or stress about the future. Psychological support and clear information can help people and families cope better. ecommons.aku.edu+1
Diagnostic tests
Doctors combine the story (history), examination, and several tests to confirm CMT2O and rule out other causes of neuropathy.
Physical-exam-based assessments
Full neurologic and general physical examination – the doctor looks at muscle size, movement, reflexes, and sensation from head to toe. In CMT2O they often find thin lower-leg muscles, weak ankle dorsiflexion, reduced ankle reflexes, and lower-limb sensory loss, while other systems are mostly normal. ecommons.aku.edu+2uniprot.org+2
Gait and posture analysis – the doctor watches how the person walks, turns, and stands. A high-stepping gait, foot slap, ankle instability, or difficulty walking on heels is typical of axonal CMT, including CMT2O. ecommons.aku.edu+2cmtausa.org+2
Inspection of feet and spine – the clinician closely examines foot shape, toe position, and spinal alignment, looking for pes cavus, hammertoes, and scoliosis that point to a long-standing hereditary neuropathy rather than a recent nerve injury. MalaCards+2uniprot.org+2
Reflex testing – using a reflex hammer, the doctor taps the tendons at the ankles and knees. In CMT2O, ankle reflexes are usually reduced or absent, helping distinguish it from conditions with exaggerated reflexes alone. ecommons.aku.edu+2uniprot.org+2
Manual bedside tests
Manual muscle testing (MRC grading) – the doctor tests strength by applying resistance with their hands and grading force from 0 to 5. This helps map out which muscles are weak, usually ankle dorsiflexors and toe extensors first in CMT2O. ecommons.aku.edu+2uniprot.org+2
Detailed sensory testing with simple tools – cotton, a blunt pin, and warm/cool objects are used to check light touch, pain, and temperature in feet and hands. Reduced feeling in a “stocking-glove” pattern is typical for length-dependent neuropathies. ecommons.aku.edu+1
Vibration sense with a tuning fork – a tuning fork is placed on bony areas like the big toe to see how long the person feels vibration. Shortened vibration sense is common in hereditary neuropathies like CMT2O. ecommons.aku.edu+2MedlinePlus+2
Romberg test for balance – the patient stands with feet together, arms by the side, first with eyes open then closed. Swaying or falling when the eyes close suggests impaired position sense from peripheral neuropathy. ecommons.aku.edu+1
Heel-to-toe and tiptoe walking tests – walking in a straight line by placing one foot directly in front of the other (tandem gait), walking on heels, and walking on toes all help show subtle balance problems and weakness in specific groups of leg muscles. ecommons.aku.edu+2MedlinePlus+2
Laboratory and pathological tests
Basic blood tests to rule out acquired causes – blood sugar, vitamin B12, thyroid function, kidney function, and other tests are checked to exclude common acquired neuropathies. Normal results support a hereditary cause like CMT2O. MedlinePlus+1
Targeted DYNC1H1 gene sequencing – if CMT2O is suspected, sequencing of the DYNC1H1 gene can detect a pathogenic variant, giving a precise genetic diagnosis. This is now a key test for confirming CMT2O. deciphergenomics.org+2MalaCards+2
CMT multigene panel or whole-exome sequencing – in many centers, a broad genetic panel for CMT or even exome sequencing is used. These tests look at many neuropathy genes at once and can identify DYNC1H1 mutations along with other rare CMT genes. Springer Nature Link+2cmtausa.org+2
Nerve biopsy (rarely used now) – a small piece of peripheral nerve (often sural nerve) may be removed and looked at under the microscope. In axonal CMT like CMT2O, the biopsy shows loss of large myelinated fibers with signs of chronic axonal degeneration, but this test is now less common because genetic testing is safer and more specific. Springer Nature Link+2ecommons.aku.edu+2
Muscle biopsy in unclear cases – if the diagnosis is uncertain, a muscle biopsy may be done. It usually shows changes from denervation (nerve loss) rather than primary muscle disease, helping to confirm that the main problem lies in the nerves. Springer Nature Link+2ecommons.aku.edu+2
Electrodiagnostic tests
Nerve conduction studies (NCS) – small electrical pulses are applied to nerves, and sensors record how fast and how strong the signals travel. In CMT2O, motor and sensory nerve action potentials are reduced in size, but conduction velocities are often normal or only mildly slowed, which fits an axonal neuropathy. MedlinePlus+2ecommons.aku.edu+2
Electromyography (EMG) – thin needles are placed into muscles to record their electrical activity. EMG in CMT2O shows signs of chronic denervation and reinnervation, such as large motor units and reduced recruitment, confirming a long-standing axonal process. MedlinePlus+2ecommons.aku.edu+2
F-wave and late-response studies – these special parts of nerve conduction testing check conduction along the whole length of the motor pathway. In axonal CMT, F-wave latencies may be slightly prolonged or normal, helping separate it from primarily demyelinating forms. Springer Nature Link+2ScienceDirect+2
Quantitative motor unit number estimation (MUNE) – some centers use MUNE to estimate how many functioning motor units remain in a muscle. This can give a more detailed picture of disease severity and progression in inherited neuropathies like CMT2O. ScienceDirect+2Frontiers+2
Imaging tests
MRI of brain and spinal cord (when central signs are present) – magnetic resonance imaging can look for brain malformations or white-matter changes seen in some DYNC1H1-related disorders. In typical pure CMT2O, MRI may be normal, but imaging is useful when spasticity or developmental issues raise concern for combined central involvement. NCBI+2Frontiers+2
MRI or ultrasound of muscles and peripheral nerves – imaging of leg muscles can show patterns of muscle wasting and fat replacement that match hereditary neuropathy. High-resolution ultrasound or MR neurography can sometimes show thinning of axons without the marked nerve enlargement seen in demyelinating CMT. ScienceDirect+2uniprot.org+2
Non-pharmacological treatments (therapies and others)
Physiotherapy (physical therapy)
Physiotherapy is a core treatment for CMT2O. A physiotherapist teaches safe exercises to keep joints moving, muscles strong, and balance as good as possible. Regular stretching and strengthening can slow stiffness and help prevent contractures (permanent muscle shortening). Programs are usually low-impact, like walking, cycling, and gentle resistance work, adapted to the person’s weakness and fatigue level. nhs.uk+2Physiopedia+2Occupational therapy
Occupational therapists focus on daily activities such as dressing, writing, cooking, and using a phone or computer. They suggest easier ways to do tasks, teach energy-saving strategies, and may recommend special tools like built-up pens, adapted cutlery, and bathroom aids. This helps people with CMT2O stay independent at school, work, and home. Physiopedia+1Ankle-foot orthoses (AFOs)
Many people with CMT use AFOs, which are light braces that support weak ankles and feet. AFOs help lift the front of the foot to reduce tripping, improve walking pattern, and decrease fatigue. They are custom-made after careful assessment of gait and muscle strength and must be reviewed over time as the condition changes. cmtausa.org+2www.slideshare.net+2Custom footwear and shoe inserts
Supportive shoes, high-top boots, and molded insoles can improve balance, reduce pain from high-arched or twisted feet, and spread pressure more evenly. This may prevent calluses and ulcers and make walking safer and more comfortable. Footwear is often used together with AFOs or other braces. Mayo Clinic+2cmtausa.org+2Balance and gait training
Physical therapists design balance exercises, such as standing on different surfaces, step practice, and safe obstacle walking, to reduce falls. Gait training may include treadmill walking, cueing, and practice on stairs or slopes. These exercises can improve confidence and reduce fear of falling. Charcot-Marie-Tooth Disease+1Stretching and contracture prevention
Gentle, regular stretching of calf, hamstring, and foot muscles helps keep joints flexible and prevents tight tendons, which worsen deformities and make walking harder. Stretching can be done at home every day, often combined with night splints or AFOs to maintain alignment. nhs.uk+1Strength and endurance training
Low-resistance, high-repetition exercises, such as light weights, resistance bands, and aquatic exercises, can improve muscle strength without over-tiring damaged nerves. Care is taken to avoid overwork weakness, so training is supervised at first and adjusted based on symptoms like pain and excessive fatigue. MDPI+1Aquatic (water) therapy
Water supports the body and reduces stress on weak muscles and joints. Exercises in a warm pool allow people with CMT2O to work on strength, flexibility, and balance with less risk of falling. Many patients find water therapy more comfortable and less tiring than land exercises. nhs.uk+1Assistive devices (canes, walkers, wheelchairs)
Some people benefit from canes or walkers for longer distances or uneven ground. A lightweight wheelchair or scooter may be used for long outings to prevent exhaustion and keep social participation. Using mobility aids is not a failure; it is a way to conserve energy and avoid falls. cmtausa.org+1Orthopedic monitoring for foot deformities and scoliosis
Regular visits to an orthopedic specialist help track foot shape, knee alignment, and spine curvature. Early detection of worsening deformities allows timely adjustments to braces, shoes, or exercises, and helps decide when surgery might be needed. GARD Information Center+1Pain coping strategies and psychological support
Living with chronic weakness and pain can be emotionally hard. Cognitive-behavioral therapy, relaxation training, and counseling help people manage stress, low mood, and anxiety related to CMT2O. Better coping often improves sleep and pain perception. PMC+1Fatigue management and pacing
People with CMT often feel easily tired because their muscles work harder to move. Planning rest breaks, pacing activities, and prioritizing important tasks can reduce fatigue. Occupational therapists teach pacing techniques and may suggest alternating sitting and standing jobs. Muscular Dystrophy Association+1Home and environmental modifications
Simple changes such as grab bars, non-slip mats, handrails on stairs, and good lighting help prevent falls and injuries. Rearranging furniture to create wider paths or lowering shelves can make movement safer for someone with leg weakness or balance issues. nhs.uk+1School and workplace accommodations
Extra time for walking between classes, permission to use the elevator, adapted physical education, and ergonomic seating or keyboards at work can reduce strain and fatigue. Occupational or vocational rehabilitation specialists can guide teachers and employers on reasonable adjustments. Muscular Dystrophy Association+1Genetic counseling for patient and family
Because CMT2O is autosomal dominant, each child of an affected person has a 50% chance of inheriting the faulty gene. Genetic counseling explains this risk, discusses testing options, and supports family planning decisions. It also helps relatives understand early signs and seek evaluation if needed. MedlinePlus+1Education about disease and self-care
Clear information about the nature of CMT2O, realistic expectations, and safe exercise and activity choices helps families feel more in control. Understanding that over-exertion can worsen fatigue but regular gentle activity is good prevents harmful extremes of rest or over-exercise. cmtausa.org+1Community support groups and peer networks
Support organizations for CMT offer education, practical tips, and emotional support from others living with similar problems. Sharing experiences about braces, therapies, and daily coping can help people feel less alone and more hopeful. cmtausa.org+1Nutritional counselling for healthy weight
Working with a dietitian to maintain a healthy weight reduces extra load on weak legs and feet. A balanced diet with enough protein, vitamins, and minerals supports general nerve and muscle health and helps prevent other illnesses that could worsen disability. PMC+1Fall-prevention programs
Structured fall-prevention training teaches safe movement patterns, strategies for uneven surfaces, and what to do after a fall. Exercises focus on leg strength, reaction time, and balance. Reducing falls protects bones and builds confidence. MDPI+1Regular multidisciplinary follow-up
Best care usually involves a team: neurologist, physiotherapist, occupational therapist, orthotist, orthopedic surgeon, and sometimes psychologist and geneticist. Regular follow-up allows early changes in therapy, brace adjustment, or surgery planning if deformities or symptoms worsen. Physiopedia+2Muscular Dystrophy Association+2
Drug treatments
Important: The medicines below are examples of drugs used for neuropathic pain and related symptoms in many conditions. Doses are typical adult ranges from FDA labels or guidelines; real prescribing must always be done by a doctor who knows the patient’s age, weight, kidneys, other medicines, and country rules. ScienceDirect+4FDA Access Data+4FDA Access Data+4
Gabapentin
Gabapentin is an anticonvulsant used widely for neuropathic pain such as post-herpetic neuralgia and diabetic nerve pain. It calms overactive nerve cells by affecting calcium channels in the spinal cord. Typical adult neuropathic pain doses are built up from 300 mg/day to 900–1800 mg/day in divided doses, sometimes higher. Common side effects include sleepiness, dizziness, and swelling of the legs. FDA Access Data+2FDA Access Data+2Pregabalin
Pregabalin is another gabapentinoid used for neuropathic pain conditions. It binds strongly to a part of voltage-gated calcium channels, reducing release of pain-signaling chemicals. Usual adult doses for neuropathic pain are 150–600 mg/day split in two or three doses. Side effects can include dizziness, drowsiness, weight gain, and ankle swelling, and it must be used carefully in people at risk of misuse. Wikipedia+3FDA Access Data+3FDA Access Data+3Duloxetine
Duloxetine is a serotonin-noradrenaline reuptake inhibitor (SNRI) approved for diabetic peripheral neuropathic pain. It boosts certain brain chemicals that block pain signals. For neuropathic pain, a typical adult dose is 60 mg once daily, sometimes up to 120 mg/day. Nausea, dry mouth, sleepiness, and sweating are common side effects. ScienceDirect+3FDA Access Data+3FDA Access Data+3Amitriptyline
Amitriptyline is a tricyclic antidepressant widely used at low doses for nerve pain. It works by increasing serotonin and noradrenaline in pain-modulating pathways and also blocking certain sodium channels. Typical neuropathic doses are 10–75 mg at night. Side effects can include dry mouth, constipation, sleepiness, and heart rhythm changes, so monitoring is important. northernlincolnshireapc.nhs.uk+2Wikipedia+2Nortriptyline or other TCAs
Nortriptyline and related tricyclics are sometimes used when amitriptyline causes too many side effects. They have similar mechanisms but may be slightly better tolerated. Doses are usually 10–75 mg at night. Side effects are similar—dry mouth, blurred vision, constipation, and possible heart rhythm effects—so ECG checks may be needed in adults. Physiopedia+2وزارة الصحة السعودية+2Carbamazepine / Oxcarbazepine
These anticonvulsants stabilize nerve membranes by blocking voltage-gated sodium channels. They are classic drugs for trigeminal neuralgia and sometimes other focal neuropathic pains. Typical adult doses range from 200–1200 mg/day (carbamazepine), divided, depending on response. Side effects can include dizziness, low blood counts, liver problems, and serious skin reactions, so they require careful medical supervision. neurothai.org+1Topical lidocaine patches
Lidocaine 5% patches numb superficial nerves in a painful skin area. They are placed on intact skin for limited hours each day and can reduce burning or shooting pains with very low systemic side effects. Mild local skin irritation or redness is possible. Patches are especially useful if pain is in a small, well-defined area. Physiopedia+2وزارة الصحة السعودية+2Topical high-strength capsaicin
High-concentration capsaicin patches temporarily “overload” pain fibers, causing them to send fewer signals for weeks or months after treatment. They are applied in a clinic because the first application can be uncomfortable. Side effects mainly include burning or redness at the site. They are generally reserved for focal neuropathic pain that has not responded to simpler treatments. ScienceDirect+1Tramadol (short-term, carefully supervised)
Tramadol is a weak opioid with extra serotonin and noradrenaline reuptake inhibition, used in some guidelines as second-line for neuropathic pain when first-line drugs fail. It is usually used at the lowest effective dose and for the shortest time because of risks of dependence, nausea, dizziness, and rare seizures or serotonin syndrome. ScienceDirect+2Square Pharmaceuticals+2Stronger opioids (specialist-supervised only)
In severe, resistant neuropathic pain, some adults may receive morphine or other strong opioids under specialist care. These drugs bind opioid receptors to reduce pain perception but carry high risks: dependence, constipation, sleepiness, hormone changes, and overdose. Many guidelines recommend limiting them and exploring non-opioid strategies first. PMC+2Dove Medical Press+2NSAIDs (e.g., naproxen)
Non-steroidal anti-inflammatory drugs do not directly treat neuropathic pain but may help with secondary muscle or joint pain from abnormal gait and deformities. Doses and duration must respect kidney, stomach, and heart risks. They are usually used as short-term add-ons rather than main therapy. PMC+1Muscle relaxants (e.g., baclofen, tizanidine)
If spasticity is present (which can happen in some DYNC1H1-related disorders), muscle relaxants may reduce stiffness and spasms. Baclofen acts on GABA-B receptors in the spinal cord; tizanidine works via alpha-2 adrenergic receptors. Side effects include sleepiness, weakness, and low blood pressure, so they must be titrated slowly. GARD Information Center+2MalaCards+2Botulinum toxin injections (for focal deformities/spasms)
In certain focal muscle imbalances, botulinum toxin A injections can temporarily weaken overactive muscles, improving alignment or reducing painful spasms. Effects typically last 3–4 months. Risks include too much weakness in the injected muscle and pain at the injection site. This is usually a specialist procedure. ScienceDirect+1Antidepressants for mood and pain modulation (e.g., SSRIs/SNRIs)
Besides duloxetine, other antidepressants may be used mainly for mood and anxiety but can indirectly improve pain coping. Evidence for SSRIs in neuropathic pain is weaker, and combinations with TCAs or tramadol may raise serotonin syndrome risk, so they must be used cautiously and under medical guidance. Dove Medical Press+2Right Decisions+2Sleep aids (used cautiously)
Chronic pain and discomfort can disturb sleep. Sometimes low doses of sedating antidepressants like amitriptyline or other sleep-promoting drugs are used at night. Good sleep hygiene is always tried first, and any drug is chosen carefully because many sedatives can worsen daytime fatigue or increase fall risk. Wikipedia+1Vitamin B12 (for documented deficiency)
If a person with CMT2O also has vitamin B12 deficiency, injections or high-dose tablets can help the additional neuropathy caused by low B12. This does not cure the genetic disease but prevents extra avoidable nerve damage. Side effects are usually mild, such as injection-site pain. PMC+1Vitamin D (for bone health if low)
Vitamin D is not a direct CMT2O treatment, but deficiency worsens bone health and fracture risk after falls. Supplementation within guideline ranges is used when blood levels are low, under medical supervision. Side effects from proper doses are uncommon; very high doses can cause high calcium. PMC+1Anti-spasticity intrathecal baclofen (rare, severe cases)
In severe mixed phenotypes with marked spasticity, intrathecal baclofen pumps can be used. A small device delivers baclofen directly into spinal fluid, reducing spasms with lower total doses. It requires surgery and careful follow-up and is usually reserved for complex, severe motor problems. PMC+1Combination therapy for neuropathic pain
Guidelines often suggest combining moderate doses of two drugs (for example, amitriptyline plus pregabalin, or duloxetine plus gabapentin) when one medicine alone gives only partial relief. Combinations can improve pain with fewer side effects than very high doses of one drug, but must be supervised to avoid dangerous interactions. ScienceDirect+3PMC+3Dove Medical Press+3Clinical trial medications (experimental therapies)
New treatments being studied for CMT include gene therapies, neuroprotective agents, and other experimental drugs. At present, most of these are in research and not yet standard care, and some trials target specific CMT subtypes. Participation in trials should be discussed with a neurologist and research team. PMC+2MDPI+2
Dietary molecular supplements
Note: Supplements should never replace prescribed treatment. Blood tests and medical advice are important before starting any supplement, especially in young people.
Omega-3 fatty acids (fish oil, algae oil)
Omega-3 fats help reduce inflammation and may support nerve cell membranes. Typical supplemental doses in adults are around 1–2 g/day of EPA+DHA, but exact dosing must be individualized. They may slightly improve pain and mood in chronic conditions. Side effects are usually mild (fishy taste, stomach upset), but high doses can increase bleeding risk if combined with blood thinners. PMC+1Vitamin B-complex
B1, B6, and B12 are important for nerve function and energy metabolism. In people with low levels, supplementation can help prevent extra nerve damage and fatigue. Typical doses vary by preparation (for example, B-complex tablets once daily). Excess B6 over long periods can itself harm nerves, so dosing must be safe and guided by a professional. PMC+1Vitamin D with calcium (when low)
Vitamin D helps the body absorb calcium and maintain strong bones. In chronically weak legs and feet, good bone health can reduce fracture risk. Doses are usually 600–2000 IU/day in adults, depending on blood levels and national guidelines. Too much vitamin D can cause high calcium, so blood monitoring is important. PMC+1Alpha-lipoic acid
Alpha-lipoic acid is an antioxidant sometimes used in diabetic neuropathy studies. It may reduce oxidative stress in nerves and slightly improve pain or numbness. Typical doses studied are 600–1200 mg/day. Side effects may include gastrointestinal upset or skin rash. Evidence in CMT2O is lacking, so it should be considered experimental and discussed with a doctor. PMC+1Coenzyme Q10 (CoQ10)
CoQ10 helps mitochondria make energy and has antioxidant properties. In some neuromuscular disorders it has been explored as supportive therapy. Doses often range from 100–300 mg/day. Side effects are usually mild, such as stomach discomfort. Its specific benefit for CMT2O is unproven, but it may support overall cellular energy. PMC+1Acetyl-L-carnitine
This compound supports mitochondrial energy production and may have neuroprotective effects. Some small studies in neuropathy suggest possible improvements in pain and nerve fiber regeneration. Typical studied doses are 500–1000 mg one to three times daily. Side effects can include nausea and restlessness. PMC+1Magnesium (if deficient)
Magnesium is needed for nerve signaling and muscle relaxation. Deficiency can worsen cramps and fatigue. Supplementation is usually in the range of 200–400 mg elemental magnesium per day in adults. Too much can cause diarrhea, and people with kidney disease need special caution. PMC+1Antioxidant-rich multivitamin (within safe limits)
A balanced multivitamin providing recommended daily amounts of vitamins A, C, E, and trace minerals may help cover gaps in diet and support general health. It is not a specific CMT2O treatment but helps prevent other deficiencies that could worsen weakness or fatigue. Over-supplementation, especially of fat-soluble vitamins, should be avoided. PMC+1Probiotics and gut-health support
Good gut health can improve nutrient absorption and sometimes reduce systemic inflammation. Probiotics are live “friendly” bacteria taken in capsules or yogurts. While not specific for CMT2O, they may help overall wellbeing and tolerance of some medicines that upset the stomach. PMC+1Dietary fiber (from food or supplements)
Fiber from fruits, vegetables, whole grains, or fiber supplements helps bowel function, which can be affected by some pain medicines or reduced activity. Keeping digestion regular improves comfort and may help with medication adherence. PMC+1
Regenerative / stem-cell / immunity booster drugs – current reality
There are no approved stem-cell or gene-editing drugs specifically for CMT2O yet. Research is active, but treatments are experimental. PMC+1
Gene-therapy research (DYNC1H1-targeted approaches)
Researchers are exploring gene-based treatments for CMT, such as adding a healthy gene copy, silencing a toxic gene, or editing the mutation. For CMT2O, the goal would be to correct or balance the DYNC1H1 mutation in nerve cells. These strategies are in preclinical or very early clinical phases and are not yet routine therapy. PMC+2nature.com+2Neurotrophic growth factor trials
Some experimental drugs try to mimic or boost natural nerve growth factors to protect or repair axons. They aim to improve nerve survival and function over time. So far, results in CMT conditions have been mixed, and no neurotrophic factor drug is standard for CMT2O. PMC+1HDAC6 inhibitors and similar neuroprotective agents
Preclinical work in CMT models has looked at HDAC6 inhibitors and other compounds that improve axonal transport and cytoskeleton stability. These drugs aim to correct downstream effects of gene defects like those in DYNC1H1. Most evidence is still from animal or cell studies. PMC+1General immune-modulating drugs (not routine in CMT2O)
Because CMT2O is a genetic neuropathy and not an autoimmune disease, immune-suppressing or immune-boosting drugs (like steroids or IVIG) are not standard treatments. They are mainly used for acquired immune neuropathies such as CIDP, not hereditary forms like CMT2O. cmtausa.org+1Stem-cell therapies (experimental and unproven)
Stem-cell approaches aim to replace or support damaged nerve cells, but at present there is no high-quality evidence that any commercial stem-cell product cures or stabilizes CMT2O. People should be very cautious about expensive “stem-cell clinics” without strong scientific backing or regulatory approval. PMC+1Supportive vaccines and infection prevention
While not regenerative, keeping vaccines up to date (such as flu and pneumonia vaccines where recommended) can be seen as “immune support,” because it prevents infections that might cause severe weakness or long hospital stays. This is good general medical care for people with chronic neuromuscular conditions. PMC+1
Surgical options
Foot deformity correction surgery (for pes cavus or hammer toes)
In some patients, high-arched feet and toe deformities become severe and painful or cause frequent falls. Orthopedic surgeons may straighten toes, lengthen or transfer tendons, or fuse joints to improve foot shape and stability. Surgery aims to create a more plantigrade (flat, stable) foot that fits better in shoes and reduces pain. nhs.uk+2Physiopedia+2Ankle stabilization or fusion
When ankle ligaments and muscles are too weak to hold the joint stable, operations can tighten ligaments or fuse the joint in a functional position. This may sacrifice some movement but can greatly reduce sprains and improve walking safety. It is usually considered after braces and therapy are not enough. Physiopedia+1Spinal surgery for scoliosis (rare, severe cases)
If scoliosis becomes severe, affecting lung function or causing significant pain and imbalance, spinal fusion surgery may be recommended. Metal rods and screws straighten and stabilize the spine. This is major surgery and is reserved for cases where conservative measures fail. GARD Information Center+1Tendon transfers
In tendon transfer surgery, tendons from relatively stronger muscles are re-attached to help move weaker joints, such as lifting the foot (dorsiflexion). The goal is to improve function and balance of forces in the leg or foot. Rehabilitation after surgery is essential to retrain movement patterns. Physiopedia+1Contracture release (soft-tissue surgery)
When tight muscles or tendons severely limit movement and cause pain or difficulties with braces, surgeons may lengthen or release them. For example, Achilles tendon lengthening can improve ankle dorsiflexion. This can make bracing easier and walking smoother, but needs careful post-operative physiotherapy. nhs.uk+1
Prevention and lifestyle strategies
Regular physiotherapy and home exercise help maintain strength and flexibility, slowing secondary complications like contractures. nhs.uk+1
Safe, supportive footwear and orthoses reduce falls and joint damage from abnormal gait. cmtausa.org+2www.slideshare.net+2
Healthy weight management reduces pressure on weak feet, ankles, and knees and lowers the risk of diabetes and heart disease. PMC+1
Avoiding nerve-toxic medications and toxins (for example, some chemotherapy drugs or high alcohol intake) may prevent extra nerve injury on top of CMT2O. Any new medicine should be discussed with a doctor who knows about the neuropathy. PMC+1
Vitamin sufficiency (especially B12 and D) prevents additional neuropathies or weak bones due to deficiency. PMC+1
Fall-prevention habits—using handrails, removing loose rugs, good lighting—lower fracture risk and fear of movement. nhs.uk+1
Infection prevention through vaccines and good hygiene reduces hospital stays and deconditioning that could worsen mobility. وزارة الصحة السعودية+1
Early detection of deformities by regular neurology and orthopedics check-ups allows quick adjustments of braces or therapy. GARD Information Center+1
Mental health support helps prevent depression and anxiety, which can reduce activity and worsen overall health. PMC+1
Family genetic counselling and early screening let at-risk relatives be diagnosed sooner, start supportive care early, and avoid harmful lifestyle factors. MedlinePlus+2zfin.org+2
When to see doctors
People with known or suspected CMT2O should see a neurologist or pediatric neurologist for diagnosis, genetic testing, and regular follow-up. New symptoms like sudden worsening weakness, severe pain, repeated falls, rapid change in walking, or new spine or foot deformities should prompt a medical review soon. GARD Information Center+2Muscular Dystrophy Association+2
It is also important to see a doctor before starting any new medicine or supplement, especially for nerve pain, mood, or sleep, because of possible interactions and side effects. If breathing problems, swallowing difficulty, or sudden bladder/bowel changes appear, urgent medical care is needed, as these are NOT typical mild CMT2O features and may signal another problem requiring fast treatment. PMC+2PMC+2
What to eat and what to avoid
Eat: A balanced diet with plenty of fruits, vegetables, whole grains, and lean proteins to support overall health and muscle repair. PMC+1
Eat: Sources of healthy fats like fish, nuts, seeds, and olive oil to provide omega-3s and energy without excess saturated fat. PMC+1
Eat: Calcium- and vitamin-D-rich foods (dairy, fortified plant milks, eggs, small bony fish) where culturally acceptable, to strengthen bones. PMC+1
Eat: Adequate protein from beans, lentils, fish, poultry, eggs, or tofu to help maintain muscles weakened by neuropathy. PMC+1
Eat: High-fibre foods (vegetables, fruits with skin, whole grains) to prevent constipation made worse by low activity or medicines. PMC+1
Avoid: Very high-sugar drinks and sweets that can promote weight gain and increase risk of diabetes, which itself can damage nerves. PMC+1
Avoid: Excess saturated and trans fats (fried fast food, processed snacks), which raise cardiovascular risk and weight. PMC+1
Avoid: Heavy or regular alcohol, as it can damage nerves and interact with pain medicines and antidepressants. PMC+1
Avoid: Very high-dose supplements without medical advice, especially vitamin B6 and D, which can cause nerve or bone problems at toxic levels. وزارة الصحة السعودية+1
Avoid: Crash diets or extreme restriction, which can cause nutrient lack and muscle loss, worsening weakness. PMC+1
Frequently asked questions
Is CMT2O curable?
No, CMT2O is currently not curable. It is caused by a change in the DYNC1H1 gene, which is present in all nerve cells from birth. Treatment focuses on reducing symptoms, preventing complications, and supporting independence. Research into gene and disease-modifying therapies is active but still experimental. MalaCards+2PMC+2Can physiotherapy really slow progression?
Physiotherapy cannot change the gene defect, but it can slow secondary problems like stiffness, contractures, and loss of fitness. By keeping joints flexible and muscles as strong as possible, daily activities stay easier for longer, and surgery may be delayed. nhs.uk+2MDPI+2Why are braces (AFOs) so important?
Braces support weak ankles and feet, reduce tripping, and improve walking efficiency. They can also prevent deformities from getting worse. Many people report fewer falls and less fatigue when they use well-fitted AFOs, although it can take time to get used to them. cmtausa.org+2www.slideshare.net+2Are there specific medicines just for CMT2O?
There are no FDA-approved medicines that directly treat the CMT2O gene defect. Drugs are used to treat neuropathic pain, mood, sleep, and spasticity, based on general neuropathic pain guidelines and individual symptoms. Clinical trials are exploring possible disease-modifying therapies. PMC+2ScienceDirect+2Which pain medicines are usually tried first?
International guidelines usually recommend gabapentin, pregabalin, duloxetine, or amitriptyline as first-line medicines for many neuropathic pain conditions. Doctors choose among them based on other illnesses, age, side-effect risk, and cost, then adjust or combine them if pain control is not enough. northernlincolnshireapc.nhs.uk+3PMC+3ScienceDirect+3Can CMT2O affect life expectancy?
For most people, CMT2 forms mainly cause disability rather than shortened life. Severe forms with scoliosis or breathing muscle involvement might carry more risks, but many adults with CMT2 continue to work, study, and live long lives with appropriate support. cmtausa.org+2Muscular Dystrophy Association+2Is exercise safe, or can it “use up” the nerves?
Appropriate, low- to moderate-intensity exercise is generally safe and beneficial. Very intense or prolonged exercise that causes lasting pain or unusual fatigue should be avoided. Physiotherapists help design a safe plan that respects the limits of weakened nerves and muscles. MDPI+2nhs.uk+2Should children with CMT2O play sports?
Many children can join non-contact or low-impact sports with adaptations, such as swimming, cycling, or carefully chosen school activities. The key is safety, good footwear, and avoiding high-impact or collision sports that could raise injury risk. Decisions are individual and guided by the care team. nhs.uk+1Why is genetic counseling recommended?
Because CMT2O is autosomal dominant, each child of an affected person has about a 50% chance of inheriting the mutated gene. Genetic counseling explains this risk, discusses testing options, and supports emotionally difficult choices about family planning and early diagnosis. MedlinePlus+2zfin.org+2Can diet alone treat CMT2O?
No diet can fix the underlying genetic change, but healthy eating supports nerve and muscle health, maintains a healthy weight, and prevents other illnesses. Combined with exercise and good medical care, diet is part of an overall wellness plan rather than a cure. PMC+2PMC+2Is stem-cell therapy for CMT2O available now?
At present, there is no widely accepted, proven stem-cell therapy for CMT2O. Many “stem-cell clinics” offer treatments without strong evidence or regulatory approval, and they can be costly and risky. People should discuss any such offers with their neurologist before considering them. PMC+2nature.com+2How often should someone with CMT2O see specialists?
The schedule depends on age and severity. Many people benefit from yearly or twice-yearly visits with a neurologist and physiotherapist, and more often during rapid growth in childhood or when symptoms change. Orthotic and orthopedic reviews are added as needed. Muscular Dystrophy Association+2nhs.uk+2Can CMT2O affect learning or thinking?
CMT mainly affects peripheral nerves. However, some DYNC1H1-related conditions include mild learning or movement difficulties. If school performance or behavior changes, a neuropsychological assessment can help identify specific needs and supports. GARD Information Center+2MalaCards+2What can families do day-to-day to help?
Families can encourage safe activity, support brace use, help with exercises, and create a home that reduces fall risks. Emotional support, listening, and involving the person in decisions about their own care are also very important for confidence and independence. Muscular Dystrophy Association+2Charcot-Marie-Tooth Disease+2Where can we learn more or find support?
National and international CMT organizations and rare-disease groups provide reliable information, patient stories, and updates on research and clinical trials. They also help connect families with expert centers and rehabilitation resources. cmtausa.org+2Physiopedia+2
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: December 22, 2025.
